Champions Oncology, Inc. (CSBR) Social Stream
Champions Oncology Inc (CSBR) Price Targets From Analysts
Use the tables below to see what analysts covering Champions Oncology Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 15, 2021
The Trend in the Analyst Price Target
CSBR's average price target has moved down $0.67 over the prior 144 days.
CSBR reports an average of 50.47% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CSBR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of CSBR is greater than nearly none of all US stocks.
- CSBR has a lower variance in analysts' estimates than 87.6% of Pharmaceutical Products stocks.
- The average analyst price target of CSBR is greater than 17.47% of all US stocks.
- The upside potential (average analyst target price relative to current price) of CSBR is higher than 77.34% of all US stocks.
Is CSBR a Buy, Hold or Sell? See the POWR Ratings now!